Yinghua Zhao
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Dysregulation of argininosuccinate synthase 1, phosphoenolpyruvate carboxykinase 1, and carbonyl reductase 3: Key arginine-proline metabolic mediators in mesangioproliferative glomerulopathies.
Journal: International journal of biological macromolecules
Published: July 07, 2025
IKZF1 as a potential therapeutic target for dendritic cell-mediated immunotherapy in IgA nephropathy.
Journal: Cell communication and signaling : CCS
Published: November 28, 2024
Diagnosis and latest treatment strategies of ANCA‑associated glomerulonephritis (Review).
Journal: Biomedical reports
Published: November 09, 2024
Characterization of antigen presentation capability for neoantigen-based products using targeted LC-MS/MS method.
Journal: Journal of pharmaceutical and biomedical analysis
Published: September 27, 2023
The therapeutic effect of Shenhua tablet against mesangial cell proliferation and renal inflammation in mesangial proliferative glomerulonephritis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 23, 2023
Single Cell Dissection of Epithelial-Immune Cellular Interplay in Acute Kidney Injury Microenvironment.
Journal: Frontiers in immunology
Published: January 18, 2022
Hypoxic mesenchymal stem cell-derived extracellular vesicles ameliorate renal fibrosis after ischemia-reperfusion injure by restoring CPT1A mediated fatty acid oxidation.
Journal: Stem cell research & therapy
Published: January 14, 2022
Cxcl10 deficiency attenuates renal interstitial fibrosis through regulating epithelial-to-mesenchymal transition.
Journal: Experimental cell research
Published: June 18, 2021
Urine proteome of COVID-19 patients.
Journal: Urine (Amsterdam, Netherlands)
Published: December 23, 2020
Last Updated: 09/26/2026